Clinical Trial Update: A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating gemcitabine plus bosutinib for patients with resected pancreatic cancer has been terminated. The status on ClinicalTrials.gov shows T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bosutinib (bosutinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED